3.0.0 3955 2023-01-13T04:50:07Z 2023-01-13T04:50:07Z House H HR 2005-09-29 109 hsif00 Energy and Commerce Committee House Standing hsif14 Health Subcommittee Referred to 2005-10-17T15:47:55Z Referred to 2005-09-29T14:00:00Z hsju00 Judiciary Committee House Standing hsju08 Crime and Federal Government Surveillance Subcommittee Referred to 2005-10-17T15:20:44Z Referred to 2005-09-29T14:00:05Z 2005-11-16 Sponsor introductory remarks on measure. (CR H10368-10370, H10374, H10375, H10376, H10376-10377) IntroReferral B00100 9 Library of Congress 2005-10-17 hsif14 Health Subcommittee 1 House committee actions Referred to the Subcommittee on Health. Committee 2005-10-17 hsju08 Crime and Federal Government Surveillance Subcommittee 1 House committee actions Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Committee 2005-09-29 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsju00 Judiciary Committee 2005-09-29 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100-A 9 Library of Congress 2005-09-29 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. IntroReferral H11100 2 House floor actions hsif00 Energy and Commerce Committee 2005-09-29 Introduced in House IntroReferral Intro-H 9 Library of Congress 2005-09-29 Introduced in House IntroReferral 1000 9 Library of Congress K000362 Rep. King, Steve [R-IA-5] Steve King R IA 5 N Crime and Law Enforcement Administrative procedure Business records Chemicals Commerce Consumer education Criminal justice information Department of Justice Drug abuse Drug law enforcement Drug traffic Drugs Environmental Protection Finance and Financial Sector Fines (Penalties) Foreign Trade and International Finance Government Operations and Politics Government paperwork Health Identification devices Import restrictions Law Methamphetamine Packaging Pharmacies Pharmacists Retail trade Signs and signboards Crime and Law Enforcement 00 2005-09-29 Introduced in House 2005-12-16T19:33:52Z Meth Lab Eradication Act - Amends the Controlled Substances Act to transfer ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V. Excepts pseudoephedrine contained in a product that: (1) is in the form of a liquid, liquid capsule, or liquid-filled gel capsule; (2) does not contain more than 360 milligrams of pseudoephedrine; and (3) is approved under the Federal Food, Drug, and Cosmetic Act.

Revises the definition of "regulated transaction" to exclude specified transactions involving drugs or products that the Attorney General determines are being diverted for illicit purposes. Repeals a provision requiring the Attorney General to reinstate an exemption with respect to a particular ephedrine, pseudoephedrine, or phenylpropanolamine drug product upon determining that the product is manufactured and distributed in a manner that prevents diversion.

Places restrictions on the sale of list I pseudoephedrine products and schedule V methamphetamine-related products. Requires a person selling list I products to: (1) place the products where the customers do not have direct access to them; (2) maintain a sales logbook that identifies the products, purchasers, dates, and times of sales; (3) not sell such products to persons under age 18; and (4) post on the premises a clear and conspicuous notice stating that federal law prohibits the over-the-counter purchase of more than one product containing pseudoephedrine in a 24-hour period or of more than 7,500 milligrams of pseudoephedrine within a 30-day period.

Sets penalties for violations of this Act.

Amends the Controlled Substances Import and Export Act to prohibit (with exceptions) the importation of ephedrine, pseudoephedrine, and phenylpropanolamine.

]]> Meth Lab Eradication Act Display Title Meth Lab Eradication Act Official Title as Introduced To amend the Controlled Substances Act to provide for the transfer of ephedrine, pseudoephedrine, and phenylpropanolamine to schedule V of the schedules of controlled substances, and for other purposes. Introduced in House IH Short Titles as Introduced Meth Lab Eradication Act Introduced in House 2005-09-29T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-109hr3955ih/xml/BILLS-109hr3955ih.xml 2005-11-16 Sponsor introductory remarks on measure. (CR H10368-10370, H10374, H10375, H10376, H10376-10377) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.